372 related articles for article (PubMed ID: 23202129)
1. MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors.
Birsoy K; Wang T; Possemato R; Yilmaz OH; Koch CE; Chen WW; Hutchins AW; Gultekin Y; Peterson TR; Carette JE; Brummelkamp TR; Clish CB; Sabatini DM
Nat Genet; 2013 Jan; 45(1):104-8. PubMed ID: 23202129
[TBL] [Abstract][Full Text] [Related]
2. Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.
Vander Linden C; Corbet C; Bastien E; Martherus R; Guilbaud C; Petit L; Wauthier L; Loriot A; De Smet C; Feron O
Cell Rep; 2021 Jun; 35(9):109202. PubMed ID: 34077729
[TBL] [Abstract][Full Text] [Related]
3. [Monocarboxylate transporter 1 enhances the sensitivity of breast cancer cells to 3-bromopyruvate in vitro].
Li QX; Zhang P; Liu F; Wang XZ; Li L; Wang ZK; Jiang CC; Zheng HL; Liu H
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):588-593. PubMed ID: 28539279
[TBL] [Abstract][Full Text] [Related]
4. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.
Hong CS; Graham NA; Gu W; Espindola Camacho C; Mah V; Maresh EL; Alavi M; Bagryanova L; Krotee PAL; Gardner BK; Behbahan IS; Horvath S; Chia D; Mellinghoff IK; Hurvitz SA; Dubinett SM; Critchlow SE; Kurdistani SK; Goodglick L; Braas D; Graeber TG; Christofk HR
Cell Rep; 2016 Feb; 14(7):1590-1601. PubMed ID: 26876179
[TBL] [Abstract][Full Text] [Related]
5. Blocking lactate export by inhibiting the Myc target MCT1 Disables glycolysis and glutathione synthesis.
Doherty JR; Yang C; Scott KE; Cameron MD; Fallahi M; Li W; Hall MA; Amelio AL; Mishra JK; Li F; Tortosa M; Genau HM; Rounbehler RJ; Lu Y; Dang CV; Kumar KG; Butler AA; Bannister TD; Hooper AT; Unsal-Kacmaz K; Roush WR; Cleveland JL
Cancer Res; 2014 Feb; 74(3):908-20. PubMed ID: 24285728
[TBL] [Abstract][Full Text] [Related]
6. CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.
Le Floch R; Chiche J; Marchiq I; Naiken T; Ilc K; Murray CM; Critchlow SE; Roux D; Simon MP; Pouysségur J
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16663-8. PubMed ID: 21930917
[TBL] [Abstract][Full Text] [Related]
7. Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters.
Gan L; Xiu R; Ren P; Yue M; Su H; Guo G; Xiao D; Yu J; Jiang H; Liu H; Hu G; Qing G
Oncogene; 2016 Jun; 35(23):3037-48. PubMed ID: 26434591
[TBL] [Abstract][Full Text] [Related]
8. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate.
Nilsson H; Lindgren D; Mandahl Forsberg A; Mulder H; Axelson H; Johansson ME
Cell Death Dis; 2015 Jan; 6(1):e1585. PubMed ID: 25569102
[TBL] [Abstract][Full Text] [Related]
9. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells.
Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y
Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495
[TBL] [Abstract][Full Text] [Related]
10. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
[TBL] [Abstract][Full Text] [Related]
11. 3-Bromopyruvate inhibits the malignant phenotype of malignantly transformed macrophages and dendritic cells induced by glioma stem cells in the glioma microenvironment via miR-449a/MCT1.
Sheng Y; Jiang Q; Dong X; Liu J; Liu L; Wang H; Wang L; Li H; Yang X; Dong J
Biomed Pharmacother; 2020 Jan; 121():109610. PubMed ID: 31710894
[TBL] [Abstract][Full Text] [Related]
12. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin.
Marchiq I; Le Floch R; Roux D; Simon MP; Pouyssegur J
Cancer Res; 2015 Jan; 75(1):171-80. PubMed ID: 25403912
[TBL] [Abstract][Full Text] [Related]
13. Combined 18F-FDG PET/CT imaging and a gastric orthotopic xenograft model in nude mice are used to evaluate the efficacy of glycolysis-targeted therapy.
Wang TA; Xian SL; Guo XY; Zhang XD; Lu YF
Oncol Rep; 2018 Jan; 39(1):271-279. PubMed ID: 29115645
[TBL] [Abstract][Full Text] [Related]
14. Monocarboxylate transporter 1 promotes classical microglial activation and pro-inflammatory effect via 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3.
Kong L; Wang Z; Liang X; Wang Y; Gao L; Ma C
J Neuroinflammation; 2019 Nov; 16(1):240. PubMed ID: 31779643
[TBL] [Abstract][Full Text] [Related]
15. Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.
Ferro S; Azevedo-Silva J; Casal M; Côrte-Real M; Baltazar F; Preto A
Oncotarget; 2016 Oct; 7(43):70639-70653. PubMed ID: 28874966
[TBL] [Abstract][Full Text] [Related]
16. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
17. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
18. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.
Linke C; Wösle M; Harder A
BMC Cancer; 2020 Sep; 20(1):896. PubMed ID: 32948135
[TBL] [Abstract][Full Text] [Related]
20. Lactate activates HIF-1 in oxidative but not in Warburg-phenotype human tumor cells.
De Saedeleer CJ; Copetti T; Porporato PE; Verrax J; Feron O; Sonveaux P
PLoS One; 2012; 7(10):e46571. PubMed ID: 23082126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
